These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 24535756

  • 1. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
    Brentnall AR, Vasiljević N, Scibior-Bentkowska D, Cadman L, Austin J, Szarewski A, Cuzick J, Lorincz AT.
    Int J Cancer; 2014 Sep 15; 135(6):1425-32. PubMed ID: 24535756
    [Abstract] [Full Text] [Related]

  • 2. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
    Hernández-López R, Lorincz AT, Torres-Ibarra L, Reuter C, Scibior-Bentkowska D, Warman R, Nedjai B, Mendiola-Pastrana I, León-Maldonado L, Rivera-Paredez B, Ramírez-Palacios P, Lazcano-Ponce E, Cuzick J, Salmerón J, FRIDA Study Group.
    Clin Epigenetics; 2019 Oct 12; 11(1):140. PubMed ID: 31606044
    [Abstract] [Full Text] [Related]

  • 3. HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier.
    Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Cadman L, Austin J, Cuzick J, Lorincz AT.
    Cancer Biomark; 2015 Oct 12; 15(5):669-75. PubMed ID: 26406956
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep 12; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 6. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.
    Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, Herrero R, Hildesheim A, Wacholder S, Scibior-Bentkowska D, Burk RD, Lorincz AT.
    Int J Cancer; 2013 Mar 15; 132(6):1412-22. PubMed ID: 22847263
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Validation of a DNA methylation HPV triage classifier in a screening sample.
    Lorincz AT, Brentnall AR, Scibior-Bentkowska D, Reuter C, Banwait R, Cadman L, Austin J, Cuzick J, Vasiljević N.
    Int J Cancer; 2016 Jun 01; 138(11):2745-51. PubMed ID: 26790008
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis.
    Kelly H, Benavente Y, Pavon MA, De Sanjose S, Mayaud P, Lorincz AT.
    Br J Cancer; 2019 Nov 01; 121(11):954-965. PubMed ID: 31616037
    [Abstract] [Full Text] [Related]

  • 14. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.
    Louvanto K, Franco EL, Ramanakumar AV, Vasiljević N, Scibior-Bentkowska D, Koushik A, Cuzick J, Coutlée F, Lorincz AT, Biomarkers of Cervical Cancer Risk Study Team.
    Int J Cancer; 2015 Mar 15; 136(6):E638-45. PubMed ID: 25203794
    [Abstract] [Full Text] [Related]

  • 15. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
    Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD.
    J Natl Cancer Inst; 2012 Nov 21; 104(22):1738-49. PubMed ID: 23093560
    [Abstract] [Full Text] [Related]

  • 16. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.
    Sun C, Reimers LL, Burk RD.
    Gynecol Oncol; 2011 Apr 21; 121(1):59-63. PubMed ID: 21306759
    [Abstract] [Full Text] [Related]

  • 17. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT, Heideman DA, Steenbergen RD, Coupé VM, Overmeer RM, Rijkaart D, Berkhof J, Meijer CJ, Snijders PJ.
    Clin Cancer Res; 2011 Apr 15; 17(8):2459-65. PubMed ID: 21389098
    [Abstract] [Full Text] [Related]

  • 18. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis.
    Bowden SJ, Kalliala I, Veroniki AA, Arbyn M, Mitra A, Lathouras K, Mirabello L, Chadeau-Hyam M, Paraskevaidis E, Flanagan JM, Kyrgiou M.
    EBioMedicine; 2019 Dec 15; 50():246-259. PubMed ID: 31732479
    [Abstract] [Full Text] [Related]

  • 19. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
    Bukowski A, Hoyo C, Hudgens MG, Brewster WR, Valea F, Bentley RC, Vidal AC, Maguire RL, Schmitt JW, Murphy SK, North KE, Smith JS.
    Cancer Epidemiol Biomarkers Prev; 2022 Aug 02; 31(8):1564-1571. PubMed ID: 35654413
    [Abstract] [Full Text] [Related]

  • 20. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    van Leeuwen RW, Oštrbenk A, Poljak M, van der Zee AGJ, Schuuring E, Wisman GBA.
    Int J Cancer; 2019 Feb 15; 144(4):746-754. PubMed ID: 30259973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.